CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Fuze	Common Stock	Common Stock Fuze	Additional Paid-in Capital	Additional Paid-in Capital Fuze	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2023			114,659,000
Beginning balance at Mar. 31, 2023	$ 99,906		$ 115		$ 905,635		$ (12,927)	$ (792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			3,535,000
Issuance of common stock under stock plans	0		$ 3		(3)
Stock-based compensation expense	18,559				18,559
Issuance of common stock under stock plans, less withholding, related to Fuze acquisition (in shares)				1,038,000
Issuance of common stock under stock plans, related to Fuze Acquisition		$ 0		$ 1		$ (1)
Unrealized investment gain (loss)	290						290
Foreign currency translation adjustment	1,441						1,441
Net income (loss)	(15,327)							(15,327)
Ending balance (in shares) at Jun. 30, 2023			119,232,000
Ending balance at Jun. 30, 2023	104,869		$ 119		924,190		(11,196)	(808,244)
Beginning balance (in shares) at Mar. 31, 2023			114,659,000
Beginning balance at Mar. 31, 2023	99,906		$ 115		905,635		(12,927)	(792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized investment gain (loss)	281
Net income (loss)	(44,001)
Ending balance (in shares) at Dec. 31, 2023			123,220,000
Ending balance at Dec. 31, 2023	109,672		$ 123		956,005		(9,538)	(836,918)
Beginning balance (in shares) at Jun. 30, 2023			119,232,000
Beginning balance at Jun. 30, 2023	104,869		$ 119		924,190		(11,196)	(808,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			1,784,000
Issuance of common stock under stock plans	0		$ 2		(2)
ESPP share issuance (in shares)			843,000
ESPP share issuance	2,366		$ 1		2,365
Stock-based compensation expense	14,940				14,940
Unrealized investment gain (loss)	7						7
Foreign currency translation adjustment	(4,320)						(4,320)
Net income (loss)	(7,452)							(7,452)
Ending balance (in shares) at Sep. 30, 2023			121,859,000
Ending balance at Sep. 30, 2023	110,410		$ 122		941,493		(15,509)	(815,696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			1,361,000
Issuance of common stock under stock plans	0		$ 1		(1)
Stock-based compensation expense	14,513				14,513
Unrealized investment gain (loss)	(16)						(16)
Foreign currency translation adjustment	5,987						5,987
Net income (loss)	(21,222)							(21,222)
Ending balance (in shares) at Dec. 31, 2023			123,220,000
Ending balance at Dec. 31, 2023	$ 109,672		$ 123		956,005		(9,538)	(836,918)
Beginning balance (in shares) at Mar. 31, 2024	125,193,573		125,194,000
Beginning balance at Mar. 31, 2024	$ 101,958		$ 125		973,895		(11,553)	(860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			2,769,000
Issuance of common stock under stock plans	0		$ 3		(3)
Stock-based compensation expense	13,279				13,279
Unrealized investment gain (loss)	(5)						(5)
Foreign currency translation adjustment	(354)						(354)
Net income (loss)	(10,290)							(10,290)
Ending balance (in shares) at Jun. 30, 2024			127,963,000
Ending balance at Jun. 30, 2024	$ 104,588		$ 128		987,171		(11,912)	(870,799)
Beginning balance (in shares) at Mar. 31, 2024	125,193,573		125,194,000
Beginning balance at Mar. 31, 2024	$ 101,958		$ 125		973,895		(11,553)	(860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized investment gain (loss)	(5)
Net income (loss)	$ (21,811)
Ending balance (in shares) at Dec. 31, 2024	131,472,684		131,473,000
Ending balance at Dec. 31, 2024	$ 113,013		$ 131		1,008,072		(12,870)	(882,320)
Beginning balance (in shares) at Jun. 30, 2024			127,963,000
Beginning balance at Jun. 30, 2024	104,588		$ 128		987,171		(11,912)	(870,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			1,479,000
Issuance of common stock under stock plans	0		$ 2		(2)
ESPP share issuance (in shares)			1,075,000
ESPP share issuance	1,683		$ 1		1,682
Stock-based compensation expense	9,721				9,721
Foreign currency translation adjustment	8,363						8,363
Net income (loss)	(14,543)							(14,543)
Ending balance (in shares) at Sep. 30, 2024			130,517,000
Ending balance at Sep. 30, 2024	109,812		$ 131		998,572		(3,549)	(885,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)			1,034,000
Issuance of common stock under stock plans	(1)				(1)
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)			(78,000)
Common shares withheld for settlement of taxes in connection with equity-based compensation	(205)				(205)
Stock-based compensation expense	9,706				9,706
Unrealized investment gain (loss)	0
Foreign currency translation adjustment	(9,321)						(9,321)
Net income (loss)	$ 3,022							3,022
Ending balance (in shares) at Dec. 31, 2024	131,472,684		131,473,000
Ending balance at Dec. 31, 2024	$ 113,013		$ 131		$ 1,008,072		$ (12,870)	$ (882,320)